Evidence map›Paper›PMID 30543456›Full record

ArticleAnnals of the American Thoracic Society2019

Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Ezra R Miller, Rachel K Putman, Alejandro A Diaz, Hanfei Xu, Raúl San José Estépar, Tetsuro Araki, Mizuki Nishino, Sergio Poli de Frías, Tomoyuki Hida, James Ross and 8 more

Abstract readMulticenter Study
In one paragraph

Article in Annals of the American Thoracic Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Update in Interstitial Lung Disease 2019.American journal of respiratory and critical care medicine · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Ezra R Miller1 Pulmonary Critical Care Medicine.
Rachel K Putman1 Pulmonary Critical Care Medicine.
Alejandro A Diaz1 Pulmonary Critical Care Medicine.
Hanfei Xu2 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Raúl San José Estépar3 Department of Radiology.ORCID 0000-0002-3677-1996
Tetsuro Araki3 Department of Radiology.
Mizuki Nishino4 Center for Pulmonary Functional Imaging.
Sergio Poli de Frías1 Pulmonary Critical Care Medicine.
Tomoyuki Hida4 Center for Pulmonary Functional Imaging.
James Ross5 Laboratory of Mathematics in Imaging, Department of Radiology, and.
Harvey Coxson6 Department of Radiology, Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada; and.
Josée Dupuis2 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
George T O'Connor7 Pulmonary, Allergy, Sleep & Critical Care Medicine Division, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.
Edwin K Silverman1 Pulmonary Critical Care Medicine.
Ivan O Rosas1 Pulmonary Critical Care Medicine.
Hiroto Hatabu3 Department of Radiology.
George Washko1 Pulmonary Critical Care Medicine.
Gary M Hunninghake1 Pulmonary Critical Care Medicine.

Funding

The New England Precision Medicine Consortium of the All of Us Research ProgramOT2OD026553 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI CLARK, CHERYL RENEE, KARLSON, ELIZABETH W · 2018 to 2023
$58.8M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ELIAS, JACK A · 2013 to 2025
$24.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
Clinical Genetics and Screening for Pulmonary FibrosisR01HL130974 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARY MATTHEW HUNNINGHAKE, Benjamin Alexander Raby · 2016 to 2026
$10.0M
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung AbnormalitiesR01HL135142 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL H. CHO, GARY MATTHEW HUNNINGHAKE · 2017 to 2026
$7.7M
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and GeneticsR01HL133135 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORITZ, ROBERT L, SILVERMAN, EDWIN K · 2017 to 2025
$7.2M
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4M
Identifying Genetic Determinants of Severe, Early-Onset COPDR01HL113264 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H., SILVERMAN, EDWIN K · 2012 to 2016
$6.0M
The clinical impact of pulmonary vascular remodeling in smokersR01HL116473 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAN JOSE ESTEPAR, RAUL, WASHKO, GEORGE R · 2013 to 2021
$5.0M
Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary FibrosisU01HL133232 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CRINER, GERARD J, DUNCAN, STEVEN R · 2017 to 2021
$3.8M
NCI NIH HHS R01 CA203636NHLBI NIH HHS K01 HL118714NHLBI NIH HHS K08 HL140087NHLBI NIH HHS K25 HL104085NHLBI NIH HHS K25 HL130637NHLBI NIH HHS N01 HC025195NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01 HL113264NHLBI NIH HHS R01 HL116473NHLBI NIH HHS R01 HL122464NHLBI NIH HHS R01 HL129920NHLBI NIH HHS R01 HL130974NHLBI NIH HHS R01 HL133135NHLBI NIH HHS R01 HL133137NHLBI NIH HHS R01 HL135142NHLBI NIH HHS R01 HL137927NHLBI NIH HHS T32 HL007633NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NHLBI NIH HHS U01 HL133232NIH HHS OT2 OD026553
6 · The paper itself

Abstract

rationaleThere is increasing evidence that aberrant processes occurring in the airways may precede the development of idiopathic pulmonary fibrosis (IPF); however, there has been no prior confirmatory data derived from imaging studies.

objectivesTo assess quantitative measures of airway wall thickness (AWT) in populations characterized for interstitial lung abnormalities (ILA) and for IPF.

methodsComputed tomographic imaging of the chest and measures of AWT were available for 6,073, 615, 1,167, and 38 participants from COPDGene (Genetic Epidemiology of COPD study), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study), and the Framingham Heart Study (FHS) and in patients with IPF from the Brigham and Women's Hospital Herlihy Registry, respectively. To evaluate these associations, we used multivariable linear regression to compare a standardized measure of AWT (the square root of AWT for airways with an internal perimeter of 10 mm [Pi10]) and characterizations of ILA and IPF by computed tomographic imaging of the chest.

resultsIn COPDGene, ECLIPSE, and FHS, research participants with ILA had increased measures of Pi10 compared with those without ILA. Patients with IPF had mean measures of Pi10 that were even greater than those noted in research participants with ILA. After adjustment for important covariates (e.g., age, sex, race, body mass index, smoking behavior, and chronic obstructive pulmonary disease severity when appropriate), research participants with ILA had increased measures of Pi10 compared with those without ILA (0.03 mm in COPDGene, 95% confidence interval [CI], 0.02-0.03; P < 0.001; 0.02 mm in ECLIPSE, 95% CI, 0.005-0.04; P = 0.01; 0.07 mm in FHS, 95% CI, 0.01-0.1; P = 0.01). Compared with COPDGene participants without ILA older than 60 years of age, patients with IPF were also noted to have increased measures of Pi10 (2.0 mm, 95% CI, 2.0-2.1; P < 0.001). Among research participants with ILA, increases in Pi10 were correlated with reductions in lung volumes in some but not all populations.

conclusionsThese results demonstrate that measurable increases in AWT are consistently noted in research participants with ILA and in patients with IPF. These findings suggest that abnormalities of the airways may play a role in, or be correlated with, early pathogenesis of pulmonary fibrosis.

Indexed as

AdultAgedCohort StudiesFemaleHumansIdiopathic Pulmonary FibrosisLinear ModelsLogistic ModelsLungLung Diseases, InterstitialMaleMiddle AgedMultivariate AnalysisPulmonary EmphysemaRegistriesSpirometryairwaysidiopathic pulmonary fibrosisinterstitial lung abnormalitieslung capacitysquare root of AWT for airways with an internal perimeter of 10 mm

Identifiers

PMID30543456
PMCPMC6441702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.